Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply.
Maturi RK, Pollack A, Uy HS, Varano M, Gomes AM, Li XY, Cui H, Lou J, Hashad Y, Whitcup SM. Maturi RK, et al. Retina. 2017 Mar;37(3):e37-e40. doi: 10.1097/IAE.0000000000001548. Retina. 2017. PMID: 28225729 No abstract available.
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM; Ozurdex MEAD Study Group. Boyer DS, et al. Among authors: maturi rk. Ophthalmology. 2014 Oct;121(10):1904-14. doi: 10.1016/j.ophtha.2014.04.024. Epub 2014 Jun 4. Ophthalmology. 2014. PMID: 24907062 Free article. Clinical Trial.
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial.
Kuppermann BD, Goldstein M, Maturi RK, Pollack A, Singer M, Tufail A, Weinberger D, Li XY, Liu CC, Lou J, Whitcup SM; Ozurdex® ERIE Study Group. Kuppermann BD, et al. Among authors: maturi rk. Ophthalmologica. 2015;234(1):40-54. doi: 10.1159/000381865. Epub 2015 Jun 18. Ophthalmologica. 2015. PMID: 26088793 Free article. Clinical Trial.
Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).
Yoon YH, Boyer DS, Maturi RK, Bandello F, Belfort R Jr, Augustin AJ, Li XY, Bai Z, Hashad Y; Ozurdex MEAD Study Group. Yoon YH, et al. Among authors: maturi rk. Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2639-2653. doi: 10.1007/s00417-019-04464-2. Epub 2019 Oct 25. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31654188 Clinical Trial.
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study.
Kunimoto D, Yoon YH, Wykoff CC, Chang A, Khurana RN, Maturi RK, Agostini H, Souied E, Chow DR, Lotery AJ, Ohji M, Bandello F, Belfort R Jr, Li XY, Jiao J, Le G, Schmidt W, Hashad Y; CEDAR and SEQUOIA Study Groups. Kunimoto D, et al. Among authors: maturi rk. Ophthalmology. 2020 Oct;127(10):1331-1344. doi: 10.1016/j.ophtha.2020.03.035. Epub 2020 Apr 9. Ophthalmology. 2020. PMID: 32471729 Free article. Clinical Trial.
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration.
Khurana RN, Kunimoto D, Yoon YH, Wykoff CC, Chang A, Maturi RK, Agostini H, Souied E, Chow DR, Lotery AJ, Ohji M, Bandello F, Belfort R Jr, Li XY, Jiao J, Le G, Kim K, Schmidt W, Hashad Y; CEDAR and SEQUOIA Study Groups. Khurana RN, et al. Among authors: maturi rk. Ophthalmology. 2021 Jul;128(7):1027-1038. doi: 10.1016/j.ophtha.2020.11.017. Epub 2020 Nov 19. Ophthalmology. 2021. PMID: 33221326 Free article. Clinical Trial.
Reply: To PMID 24531021.
Chang W, Garg SJ, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC, Maturi R. Chang W, et al. Am J Ophthalmol. 2015 Feb;159(2):404-5. doi: 10.1016/j.ajo.2014.10.022. Am J Ophthalmol. 2015. PMID: 25542554 No abstract available.
111 results